SCHEMBL7805091

SCHEMBL7805091

Fc1ccsc1CI

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2131664 0.75
SCHEMBL9925417 0.75
SCHEMBL1475136 0.75
SCHEMBL13845083 0.71
SCHEMBL2093318 0.71
SCHEMBL1789332 0.70
SCHEMBL11186584 0.69 ALDH1A1 (0.38)
Hydrochloric Acid SCHEMBL15618909 0.69 CYP3A4 (0.35)
SCHEMBL20764816 0.69 CA2 (0.34)
SCHEMBL31094645 0.66 LTB4R (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010148488-A1 CATHEPSIN CYSTEINE PROTEASE INHIBITORS FOR THE TREATMENT OF VARIOUS DISEASES MERCK FROSST CANADA LTD. (CA) 2010-12-29 WO disclosed